Belgium’s Ceres Pharma has expanded its business at home and abroad with two separate acquisitions to grow its dietary supplements portfolio.
First, the company has struck a deal to acquire 100% of the shares of Labophar from owner Dovesco for an undisclosed sum
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?